Etid klinik pou Menenjyom nan New York
9 etid pou Menenjyom ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Glens Falls Hospital, Glens Falls
- Northwell Health/Center for Advanced Medicine, Lake Success
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- ak 2 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- NYU Lagone Health, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06955169A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Memorial Sloan-Kettering Cancer Center, New York
- Mayo Clinic_Rochester, Rochester
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07428616Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- New York University Langone Medical Center, New York
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04374305A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
- NYU- Langone Health, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT07533942Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Albany Medical Center, Albany
- SUNY Upstate Medical Center, Syracuse
- Montefiore Einstein, The Bronx
- ak 1 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT04427384Cabozantinib for Patients With Recurrent or Progressive Meningioma
- Memorial Sloan Kettering Cancer Center, New York
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT05425004Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE
- New York-Presbyterian/Weill Cornell Medical Center, New York
Ap rekriteFaz 4
Laj 18 a 99 · Tout sèks · Mizajou Feb 27, 2026 · NCT0637737168-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
- Weill Cornell Medicine, New York
Ap rekriteFaz 4
Laj 18 a 100 · Tout sèks · Mizajou Nov 21, 2025 · NCT04081701Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.